# Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-analysis-of-incretin-therapy-for-type-2-diabetes-in-spain-1-8/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Antonio Pérez,Pedro Mezquita Raya,Antonio Ramírez de Arellano,Teresa Briones,Barnaby Hunt,William J. Valentine |
| Citations | 30 |
| DOI | 10.1007/s13300-015-0103-5 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://link.springer.com/content/pdf/10.1007/s13300-015-0103-5.pdf |
| OpenAlex ID | https://openalex.org/W1976618350 |
| PMID | 25742705 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Antonio Ramírez de Arellano](https://scholariq.org/researchers/antonio-ramirez-de-arellano/)

## Paper journal

- [Diabetes Therapy](https://scholariq.org/journals/diabetes-therapy/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Pharmacology and Obesity Treatment](https://scholariq.org/topics/pharmacology-and-obesity-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.